Deciphering the enzymatic target of a new family of antischistosomal agents bearing a quinazoline scaffold using complementary computational tools

Abstract A previous phenotypic screening campaign led to the identification of a quinazoline derivative with promising in vitro activity against Schistosoma mansoni. Follow-up studies of the antischistosomal potential of this candidate are presented here. The in vivo studies in a S. mansoni mouse model show a significant reduction of total worms and a complete disappearance of immature eggs when administered concomitantly with praziquantel in comparison with the administration of praziquantel alone. This fact is of utmost importance because eggs are responsible for the pathology and transmission of the disease. Subsequently, the chemical optimisation of the structure in order to improve the metabolic stability of the parent compound was carried out leading to derivatives with improved drug-like properties. Additionally, the putative target of this new class of antischistosomal compounds was envisaged by using computational tools and the binding mode to the target enzyme, aldose reductase, was proposed. Graphical Abstract

[1]  The UniProt Consortium,et al.  UniProt: a worldwide hub of protein knowledge , 2018, Nucleic Acids Res..

[2]  P E Bourne,et al.  The Protein Data Bank. , 2002, Nucleic acids research.

[3]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[4]  R. H. Duvall,et al.  An improved perfusion technique for recovering adult schistosomes from laboratory animals. , 1967, The American journal of tropical medicine and hygiene.

[5]  R. Maizels,et al.  Human schistosomiasis in the post mass drug administration era. , 2017, The Lancet. Infectious diseases.

[6]  E. Davioud‐Charvet,et al.  Thioredoxin Glutathione Reductase from Schistosoma mansoni: An Essential Parasite Enzyme and a Key Drug Target , 2007, PLoS medicine.

[7]  D. Rollinson,et al.  Outbreak of urogenital schistosomiasis in Corsica (France): an epidemiological case study. , 2016, The Lancet. Infectious diseases.

[8]  Daniel Bischoff,et al.  The power of combining phenotypic and target-focused drug discovery. , 2019, Drug discovery today.

[9]  V. O’Donnell,et al.  Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells , 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  Chuan-Xin Yu,et al.  Thioredoxin Glutathione Reductase as a Novel Drug Target: Evidence from Schistosoma japonicum , 2012, PloS one.

[11]  D. Eisenberg,et al.  Assessment of protein models with three-dimensional profiles , 1992, Nature.

[12]  Jean-Louis Reymond,et al.  The polypharmacology browser: a web-based multi-fingerprint target prediction tool using ChEMBL bioactivity data , 2017, Journal of Cheminformatics.

[13]  D. Cioli,et al.  Sex- and stage-related sensitivity of Schistosoma mansoni to in vivo and in vitro praziquantel treatment. , 2004, International journal for parasitology.

[14]  J. Boissier,et al.  Schistosomiasis chemotherapy. , 2013, Angewandte Chemie.

[15]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[16]  R. Friesner,et al.  Novel procedure for modeling ligand/receptor induced fit effects. , 2006, Journal of medicinal chemistry.

[17]  T. Yeates,et al.  Verification of protein structures: Patterns of nonbonded atomic interactions , 1993, Protein science : a publication of the Protein Society.

[18]  Zheng Yin,et al.  Improving chemical similarity ensemble approach in target prediction , 2016, Journal of Cheminformatics.

[19]  S. Cook,et al.  Redox Balance Mechanisms in Schistosoma mansoni Rely on Peroxiredoxins and Albumin and Implicate Peroxiredoxins as Novel Drug Targets* , 2006, Journal of Biological Chemistry.

[20]  S. Botros,et al.  Effect of praziquantel on the immature stages of Schistosoma haematobium. , 2005, International journal for parasitology.

[21]  Kei Mayumi,et al.  In vivo use of the CYP inhibitor 1-aminobenzotriazole to increase long-term exposure in mice. , 2016, Biopharmaceutics & drug disposition.

[22]  Matthew P. Repasky,et al.  Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes. , 2006, Journal of medicinal chemistry.

[23]  Evan Bolton,et al.  PubChem 2019 update: improved access to chemical data , 2018, Nucleic Acids Res..

[24]  Heather M. Alger,et al.  The disulfide redox system of Schistosoma mansoni and the importance of a multifunctional enzyme, thioredoxin glutathione reductase. , 2002, Molecular and biochemical parasitology.

[25]  Bin Xu,et al.  Molecular cloning and characterization of Schistosoma japonicum aldose reductase , 2013, Parasitology Research.

[26]  I. D. de Esch,et al.  Screening of a PDE-focused library identifies imidazoles with in vitro and in vivo antischistosomal activity , 2019, International journal for parasitology. Drugs and drug resistance.

[27]  A. Guidi,et al.  Schistosomiasis control: praziquantel forever? , 2014, Molecular and biochemical parasitology.

[28]  Ian H. Gilbert,et al.  Drug Discovery for Neglected Diseases: Molecular Target-Based and Phenotypic Approaches , 2013, Journal of medicinal chemistry.

[29]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[30]  D. Eisenberg,et al.  VERIFY3D: assessment of protein models with three-dimensional profiles. , 1997, Methods in enzymology.

[31]  Z. Xiang,et al.  On the role of the crystal environment in determining protein side-chain conformations. , 2002, Journal of molecular biology.

[32]  C. Pérez,et al.  Benzothiadiazine Dioxide Human Cytomegalovirus Inhibitors: Synthesis and Antiviral Evaluation of Main Heterocycle Modified Derivatives , 2003, Antiviral chemistry & chemotherapy.

[33]  J. Pellegrino,et al.  New approach to the screening of drugs in experimental schistosomiasis mansoni in mice. , 1962, American Journal of Tropical Medicine and Hygiene.

[34]  Andrea Volkamer,et al.  Advances and Challenges in Computational Target Prediction , 2019, J. Chem. Inf. Model..

[35]  Michael J. Keiser,et al.  Large Scale Prediction and Testing of Drug Activity on Side-Effect Targets , 2012, Nature.

[36]  K. Ramana,et al.  Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disorders. , 2011, Chemico-biological interactions.

[37]  Woody Sherman,et al.  Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments , 2013, Journal of Computer-Aided Molecular Design.

[38]  George Papadatos,et al.  The ChEMBL database in 2017 , 2016, Nucleic Acids Res..

[39]  David S. Goodsell,et al.  AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility , 2009, J. Comput. Chem..

[40]  A. Cheever Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues. , 1968, Bulletin of the World Health Organization.

[41]  Richard A. Friesner,et al.  Integrated Modeling Program, Applied Chemical Theory (IMPACT) , 2005, J. Comput. Chem..

[42]  David E. Gloriam,et al.  The SMARTCyp cytochrome P450 metabolism prediction server , 2010, Bioinform..

[43]  Leonardo L. G. Ferreira,et al.  Target-based molecular modeling strategies for schistosomiasis drug discovery. , 2015, Future medicinal chemistry.

[44]  Tayo Alex Adekiya,et al.  PZQ Therapy: How Close are we in the Development of Effective Alternative Anti-schistosomal Drugs? , 2019, Infectious disorders drug targets.

[45]  The structure of human recombinant aldose reductase complexed with the potent inhibitor zenarestat. , 2002, Acta crystallographica. Section D, Biological crystallography.

[46]  Michael J. Keiser,et al.  Relating protein pharmacology by ligand chemistry , 2007, Nature Biotechnology.

[47]  Ian W. Davis,et al.  Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.

[48]  D. Dyer,et al.  Aldose reductase from Schistosoma japonicum: crystallization and structure-based inhibitor screening for discovering antischistosomal lead compounds , 2013, Parasites & Vectors.